T2	total-participants 309 312	960
T3	control 519 540	no adjuvant treatment
T4	intervention 187 208	adjuvant radiotherapy
T5	outcome 942 966	risk of local recurrence
T6	outcome 1039 1068	risk of distant dissemination
T1	eligibility 212 288	early breast cancer patients with more than 15 years of follow-up evaluation
T7	outcome-Measure 1453 1469	overall survival
